South African healthtech startup, Impulse Biomedical has raised an undisclosed amount of funding from Futuregrowth through the Development Equity Fund (DEF) to expand its product offering and increase access to life-saving health technologies in South Africa.
Impulse Biomedical develops multiple medical devices, providing access to healthcare services and using effective technologies to reduce the impact of chronic illness & diseases, and help save lives. Impulse has developed some medical products which includes ZiBiPen and Easy Squeezy.
$60
(billed annually)
Access To 12-Month WT Membership
Access To WT's Conferences & Events
Access To All WT's Research Reports On Africa
Access To Podcasts, Video Content & Recordings
Access To All Premium Newsletters
Unlimited Access To WT's Content Archive